Icon
+91 94997 68112
Login Register

TRANSDERM-NITRO (nda020144)- (0.1MG/HR,0.2MG/HR,0.4MG/HR,0.6MG/HR,0.8MG/HR)

NITROGLYCERIN NOVARTIS
0.1MG/HR,0.2MG/HR,0.4MG/HR,0.6MG/HR,0.8MG/HR
Yes No
2001-Dec-04 Expired
None None
None No
Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.
4 0 4
Total Other Developers None
Drugs with Suitability No
0.1MG/HR ** ** - - 1
0.2MG/HR ** ** - 1 -
0.4MG/HR ** ** - 1 -
0.6MG/HR ** ** - 1 -
0.8MG/HR ** ** - - -
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ****** *************** *** *********** *** ******* ******* ****, *.*. *** ***, **********, ************ (**) *****, ****** ****** (***) ***
****** ***** ****** ****** *************** *** *********** *** ******* ******* ****, *.*. *** ***, **********, ************ (**) *****, ****** ****** (***) ***
****** ***** ****** ****** *************** *** *********** *** ******* ******* ****, *.*. *** ***, **********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.